0
Signs and Symptoms of Chest Diseases |

Relationship Between Survival and Age in Patients With IPF in Korean Population

So-My Koo*, MD; Soo-Taek Uh, PhD; Dong Soon Kim, PhD; Choon Sik Park, PhD
Author and Funding Information

Division of Allergy and Respiratory Medicine, Department of Internal Medicine, Soon Chun Hyang University Seoul Hospital, Seoul, Republic of Korea


Chest. 2012;142(4_MeetingAbstracts):958A. doi:10.1378/chest.1388290
Text Size: A A A
Published online

Abstract

SESSION TYPE: New Insights into Idiopathic Pulmonary Fibrosis

PRESENTED ON: Sunday, October 21, 2012 at 01:15 PM - 02:45 PM

PURPOSE: There is a controversy that the older patients with IPF have worse prognosis. We evaluated whether age can affect survival and there are differences of parameters affecting prognosis between each age group in patients with IPF.

METHODS: This retrospective observational study consisted of 1,685 patients with IPF by clinical(1,027 patients) or surgical(658 patients) diagnosis defined by the 2000 ATS/ERS consensus statement. Patients were enrolled from 54 hospitals in Korea from January 1, 2003 to December 31, 2007. There were 465 women and 1,220 men, with a mean age of 67.9(range, 30 to 94) years. They were stratified by four age groups(younger than 50 years, n=65; 50-60 years, n=252; 60-70 years, n=623; older than 70 years, n=748). We used life-table method to estimate the overall survival time. We analyzed whether there were baseline clinical characteristic differences between groups: on presence of exertional dyspnea and on presence of honeycombing by Pearson chi-square test; on diffusion capacity for carbon monoxide(DLCO,%) by ANOVA test.

RESULTS: The median survival time from the time of the diagnosis was 57.3 months in 1,685 patients. The median survival time of the group of older than 70 years was significantly shorter than those of others:[< 50 years, 63.0 months; 50-60 years, 63.0 months; 60-70 years, 65.0 months; >70 years, 38.8 months (p=0.001)]. There was a significant difference in the presence of exertional dyspnea between each groups (p=0.018) but no difference between groups under 70 years old. There was no difference on the presence of honeycomb between each groups (p=0.279). There was a significant difference in DLCO between groups (p=0.048) but no difference between each group in post hoc tests.

CONCLUSIONS: The overall survival time of the group of older than 70 years was significantly shorter than those of others and exertional dyspnea can predict poor prognosis in patients with IPF in Korean population.

CLINICAL IMPLICATIONS: Patients more than 70 years old with IPF have a poor prognosis. The baseline clinical characteristic differences between groups might influence the survival time.

DISCLOSURE: The following authors have nothing to disclose: So-My Koo, Soo-Taek Uh, Dong Soon Kim, Choon Sik Park

No Product/Research Disclosure Information

Division of Allergy and Respiratory Medicine, Department of Internal Medicine, Soon Chun Hyang University Seoul Hospital, Seoul, Republic of Korea

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Figures

Tables

References

NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

MEMBER & INDIVIDUAL SUBSCRIBER

Want Access?

NEW TO CHEST?

Become a CHEST member and receive a FREE subscription as a benefit of membership.

Individuals can purchase this article on ScienceDirect.

Individuals can purchase a subscription to the journal.

Individuals can purchase a subscription to the journal or buy individual articles.

Learn more about membership or Purchase a Full Subscription.

INSTITUTIONAL ACCESS

Institutional access is now available through ScienceDirect and can be purchased at myelsevier.com.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
Guidelines
Allergy diagnostic testing: an updated practice parameter. Part 2.
Joint Council of Allergy, Asthma and Immunology | 7/24/2009
Allergy diagnostic testing: an updated practice parameter. Part 1.
Joint Council of Allergy, Asthma and Immunology | 7/24/2009
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543